Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI
Publication date: Available online 26 June 2020Source: Regulatory Toxicology and PharmacologyAuthor(s): Carr J. Smith, Thomas A. Perfetti, A. Wallace Hayes, Sir Colin Berry
Source: Regulatory Toxicology and Pharmacology - Category: Toxicology Source Type: research
More News: Chemistry | Drugs & Pharmacology | Eating Disorders & Weight Management | Epidemiology | Obesity | Study | Toxicology